PhRMA, BIO Recommendations To PCORI Emphasize Studying Delivery Of Care Rather Than Comparing Products
The Pharmaceutical Research and Manufacturers of America and the Biotechnology Industry Organization target data on health care delivery in their recommendations for what the Patient-Centered Outcomes Research Institute should focus its attention on.
You may also be interested in...
The Patient-Centered Outcomes Research Institute will be looking to patients and other stakeholders to help set the research agenda through its website, workshops and other avenues. Forthcoming advisory panels will help prioritize the list of suggestions that will be presented to the institute’s board of governors, which will make final funding decisions.
Comments on the Patient-Centered Outcomes Research Institute’s national priorities and research agenda reveal difficulty in expressing thoughts on how the institute should allocate its research funds due to a lack of specificity in the research agenda itself.
The overall Patient-Centered Outcomes Research Institute’s research agenda offered five broad areas where it will be seeking to fund research. While four of those areas will remain broadly defined when PCORI solicits study proposals through a PCORI funding announcement in May, the PFA in the area of accelerating patient-centered outcomes research and methodological research will add some specifics on types of studies needed and be issued in July.